USPTO serial 79301285
ILZIMLIA
Reg. 6422560Status 700Renewal
- Filing date
- Nov 10, 2020
- Status date
- Jul 20, 2021
- Registration date
- Jul 20, 2021
- Examiner
- PINO, BRIAN
Need help with ILZIMLIA?
CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Deadline: July 20th, 2027
Owner
NOVARTIS AG
CH
NOVARTIS AG
CH
NOVARTIS AG
CH
Sandoz AG
CH
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma | ACTIVE | — |
Prosecution history
| Date | Code | Event |
|---|---|---|
| Jul 20, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Jan 19, 2024 | CHLD | CHANGE OF OWNER RECEIVED FROM IB |
| Dec 6, 2021 | FINV | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Nov 17, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB |
| Nov 17, 2021 | FIMP | FINAL DISPOSITION PROCESSED |
| Oct 20, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Jul 20, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER |
| May 4, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| May 4, 2021 | PUBO | PUBLISHED FOR OPPOSITION |
| May 3, 2021 | GPNX | NOTIFICATION PROCESSED BY IB |
| Apr 14, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Apr 14, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Apr 14, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Apr 1, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Mar 22, 2021 | RFNT | REFUSAL PROCESSED BY IB |
| Mar 11, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Mar 11, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Mar 11, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Mar 4, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Mar 4, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Mar 4, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Mar 4, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Mar 4, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Mar 4, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Mar 2, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Mar 2, 2021 | RFRR | REFUSAL PROCESSED BY MPU |
| Mar 2, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Mar 1, 2021 | CNRT | NON-FINAL ACTION WRITTEN |
| Feb 23, 2021 | DOCK | ASSIGNED TO EXAMINER |
| Jan 19, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED |
| Jan 14, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jan 13, 2021 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Dec 31, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB |